Mason Street Advisors, LLC Incyte Corp Transaction History

Mason Street Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $1.95 Million - $2.58 Million	-25,678 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $34,798 - $42,108	-431 Reduced 1.65%	25,678 $2.23 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $29,944 - $38,610	352 Added 1.37%	26,109 $2.34 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $18,470 - $27,123	249 Added 0.98%	25,757 $2.68 Million
Q4 2019 Feb 19, 2020	BUY	$73.04 - $95.72 $5,624 - $7,370	77 Added 0.3%	25,508 $2.23 Million
Q3 2019 Nov 05, 2019	BUY	$72.82 - $86.52 $3,422 - $4,066	47 Added 0.19%	25,431 $1.89 Million
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $2,793 - $3,370	38 Added 0.15%	25,384 $2.16 Million
Q1 2019 May 07, 2019	BUY	$63.56 - $88.17 $28,220 - $39,147	444 Added 1.78%	25,346 $2.18 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $5,733 - $6,854	98 Added 0.4%	24,902 $1.58 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $7,410 - $8,907	120 Added 0.49%	24,804 $1.71 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $12,900 - $17,803	212 Added 0.87%	24,684 $1.65 Million
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $6,146 - $7,472	74 Added 0.3%	24,472 $2.04 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $65,211 - $81,270	697 Added 2.94%	24,398 $2.31 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $2.59 Million - $3.28 Million	23,701	23,701 $2.77 Million

706

189M

909K

489K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.